201 related articles for article (PubMed ID: 17133571)
1. Liver transplantation for fulminant hepatitis related to nevirapine therapy.
Buyse S; Vibert E; Sebagh M; Antonini T; Ichai P; Castaing D; Samuel D; Duclos-Vallée JC
Liver Transpl; 2006 Dec; 12(12):1880-2. PubMed ID: 17133571
[TBL] [Abstract][Full Text] [Related]
2. Nevirapine-induced fulminant hepatitis.
Maniar JK; Shah SR; Verma R; Kamath R; Gupte P; Maniar A
J Assoc Physicians India; 2006 Dec; 54():957-8. PubMed ID: 17334017
[TBL] [Abstract][Full Text] [Related]
3. Urgent liver transplantation for nevirapine-induced acute liver failure: report of a case and review of the literature.
Lopez-Delgado JC; Mendiluce RM; Pinol TS; Fernández XP; Sanchez L; Vicente RG
Ann Transplant; 2012; 17(1):122-7. PubMed ID: 22466918
[TBL] [Abstract][Full Text] [Related]
4. Severe hepatic failure related to nevirapine treatment.
Cattelan AM; Erne E; Salatino A; Trevenzoli M; Carretta G; Meneghetti F; Cadrobbi P
Clin Infect Dis; 1999 Aug; 29(2):455-6. PubMed ID: 10476768
[No Abstract] [Full Text] [Related]
5. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
Sha BE; Proia LA; Kessler HA
JAMA; 2000 Dec; 284(21):2723. PubMed ID: 11105176
[No Abstract] [Full Text] [Related]
6. Nevirapine-induced stevens johnson-syndrome and fulminant hepatic failure requiring liver transplantation.
Jao J; Sturdevant M; del Rio Martin J; Schiano T; Fiel MI; Huprikar S
Am J Transplant; 2010 Jul; 10(7):1713-6. PubMed ID: 20642694
[TBL] [Abstract][Full Text] [Related]
7. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551
[TBL] [Abstract][Full Text] [Related]
8. Fatal outcome of nevirapine-associated toxic epidermal necrolysis.
Leng K; Lonsdorf A; Hartmann M
Int J STD AIDS; 2008 Sep; 19(9):642-3. PubMed ID: 18725560
[TBL] [Abstract][Full Text] [Related]
9. [Reliable effectiveness for years with good long-term tolerance: 10 years nevirapine--a summary].
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():70. PubMed ID: 19024921
[No Abstract] [Full Text] [Related]
10. Nevirapine-induced Stevens-Johnson syndrome in a pediatric patient.
Mason AR; Cortes GY; Pollack RB
Pediatr Dermatol; 2008; 25(1):128-9. PubMed ID: 18304177
[TBL] [Abstract][Full Text] [Related]
11. Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser.
Elsharkawy AM; Schwab U; McCarron B; Burt AD; Daly AK; Hudson M; Masson S
J Clin Virol; 2013 Sep; 58(1):331-3. PubMed ID: 23763943
[TBL] [Abstract][Full Text] [Related]
12. [Hepatic failure due to nevirapine treatment for HIV infection].
Mens H; Katzenstein TL
Ugeskr Laeger; 2005 Nov; 167(46):4359. PubMed ID: 16287519
[TBL] [Abstract][Full Text] [Related]
13. Risk for immune-mediated liver reactions by nevirapine revisited.
Medrano J; Barreiro P; Tuma P; Vispo E; Labarga P; Blanco F; Soriano V
AIDS Rev; 2008; 10(2):110-5. PubMed ID: 18615121
[TBL] [Abstract][Full Text] [Related]
14. Severe leukopenia associated with mild hepatotoxicity in an HIV carrier treated with nevirapine.
Shahar E; Krivoy N; Weltfriend S; Pollack S
Jpn J Infect Dis; 2004 Oct; 57(5):212-3. PubMed ID: 15507779
[TBL] [Abstract][Full Text] [Related]
15. Nevirapine-associated toxicity.
Imperiale M
AIDS Read; 2002 Apr; 12(4):171. PubMed ID: 12071188
[No Abstract] [Full Text] [Related]
16. Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity.
Raffi F; Lewden C; Chêne G
AIDS; 2008 Jan; 22(3):435-6. PubMed ID: 18195573
[No Abstract] [Full Text] [Related]
17. High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
Rey D; Hoen B; Chavanet P; Schmitt MP; Hoizey G; Meyer P; Peytavin G; Spire B; Allavena C; Diemer M; May T; Schmit JL; Duong M; Calvez V; Lang JM
J Antimicrob Chemother; 2009 Feb; 63(2):380-8. PubMed ID: 19036752
[TBL] [Abstract][Full Text] [Related]
18. Desensitization to Nevirapine.
TreatmentUpdate; 1999 Nov; 11(8):5. PubMed ID: 11367044
[TBL] [Abstract][Full Text] [Related]
19. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.
van Oosterhout JJ; Kumwenda JJ; Beadsworth M; Mateyu G; Longwe T; Burger DM; Zijlstra EE
Antivir Ther; 2007; 12(4):515-21. PubMed ID: 17668560
[TBL] [Abstract][Full Text] [Related]
20. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
Santos RP; Ramilo O; Barton T
Pediatr Infect Dis J; 2007 Nov; 26(11):1053-6. PubMed ID: 17984815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
